Given the immunosuppressive functions of CD73 and adenosine, these data suggest that CD73 and CD39 expression may be upregulated in tumors in response to ongoing inflammation similar to normal tissues, or that inflammation drives selection for CD73hi tumor cells and CD39hi immune cells that may support ongoing tumorigenesis. This evidence concerns the gene NT5E and neoplasm.